4.5 Article

Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Immunology

A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice

Eun Kim et al.

Summary: The Ad5-vectored SARS-CoV-2 vaccine candidate showed promising immunogenicity in mice following delivery via S.C. and I.N. routes, inducing robust antibody and cellular immune responses with long-lasting immunity. This supports further development of Ad-based vaccines for sustainable global immunization programs against COVID-19 and other infectious diseases.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

Adrian Rice et al.

Summary: The study developed a dual-antigen COVID-19 vaccine that can elicit effective humoral and T-cell responses when administered subcutaneously or intranasally, with subcutaneous prime followed by intranasal or subcutaneous boost inducing greater T cell responses.

SCIENTIFIC REPORTS (2021)

Article Immunology

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

R. Glenn King et al.

Summary: The study found that a single intranasal dose of AdCOVID vaccine can generate a strong and focused immune response against RBD, including mucosal IgA in the respiratory tract, serum neutralizing antibodies, and CD4(+) and CD8(+) T cells with a T(h)1-like cytokine expression profile. Additionally, a single AdCOVID dose can result in immunity sustained for over six months and completely protect K18-hACE2 mice from lethal SARS-CoV-2 challenge, preventing weight loss and mortality, indicating that AdCOVID promotes concomitant systemic and mucosal immunity and serves as a promising vaccine candidate.

VACCINES (2021)

Article Anesthesiology

Coronaviruses and SARS-CoV-2: A Brief Overview

Stephan Ludwig et al.

ANESTHESIA AND ANALGESIA (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Medicine, General & Internal

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

Gregory A. Poland et al.

LANCET (2020)

Article Multidisciplinary Sciences

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Liqiang Feng et al.

NATURE COMMUNICATIONS (2020)

Review Microbiology

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Wen Shi Lee et al.

NATURE MICROBIOLOGY (2020)

Review Cell Biology

Coronavirus vaccine development: from SARS and MERS to COVID-19

Yen-Der Li et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Review Biochemistry & Molecular Biology

A systematic review of SARS-CoV-2 vaccine candidates

Yetian Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Medicine, General & Internal

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention

Lindsey R. Baden et al.

ANNALS OF INTERNAL MEDICINE (2016)

Article Multidisciplinary Sciences

Pre-fusion structure of a human coronavirus spike protein

Robert N. Kirchdoerfer et al.

NATURE (2016)

Review Virology

Structure, Function, and Evolution of Coronavirus Spike Proteins

Fang Li

ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)

Review Pharmacology & Pharmacy

Adenoviral vectors as novel vaccines for influenza

Lynda Coughlan et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2015)

Review Immunology

T-cell subsets in the germinal center

Roybel R. Ramiscal et al.

IMMUNOLOGICAL REVIEWS (2013)

Review Immunology

Germinal Centers

Gabriel D. Victora et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

Review Immunology

Follicular Helper CD4 T Cells (T-FH)

Shane Crotty

ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)

Article Allergy

Overview of the immune response

David D. Chaplin

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Review Immunology

Th17 cells in human disease

Laura A. Tesmer et al.

IMMUNOLOGICAL REVIEWS (2008)

Review Biotechnology & Applied Microbiology

Adenovirus vector-based vaccines for human immunodeficiency virus type 1

DH Barouch et al.

HUMAN GENE THERAPY (2005)

Article Biotechnology & Applied Microbiology

Improvement in adenoviral gene transfer efficiency after preincubation at+37 degrees C in vitro and in vivo

M Kossila et al.

MOLECULAR THERAPY (2002)

Review Biotechnology & Applied Microbiology

Update an adenovirus and its vectors

WC Russell

JOURNAL OF GENERAL VIROLOGY (2000)